Clin2
NCT06104280Possibly a fitRecruiting

How opioid addiction meds affect sleep and eyes

Opioid Use DisorderSleep Disturbance

Part of Brain & nervous system, Mental health clinical trials.

This study tests how three common medications for opioid use disorder (methadone, buprenorphine, and naltrexone) affect eye function, sleep, and daily body rhythms. It may help find ways to improve treatment for opioid addiction.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You are prescribed methadone, extended-release naltrexone (a shot), or buprenorphine for opioid use disorder and have been on a steady dose for at least a month, OR you are a healthy person not taking these meds
  • If you are taking buprenorphine or methadone, a urine drug test must show the medication is in your system
  • You do not have any eye disease (like cataracts, glaucoma, or macular degeneration) and have not had eye surgery that might affect the study
  • You have not used any illegal opioids, stimulants (even prescribed ones like Adderall), or benzodiazepines in the past month
  • You do not work night shifts (outside 7 a.m. to 6 p.m.) and do not have narcolepsy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06832007Recruiting
Light therapy for recovery from opioid use disorder

This study tests whether a special light device used at home can improve recovery in people being treated for opioid use disorder. It looks at how light might help with sleep, mood, and overall well-being.

Birmingham, Alabama
NCT06981195Recruiting· Phase 2
Testing lemborexant for insomnia in people on buprenorphine

This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.

Richmond, Virginia
NCT06157840Recruiting
Sleep program for people on buprenorphine treatment

This trial tests a mobile health sleep program for people who are on buprenorphine for opioid use disorder and have trouble sleeping. It aims to help improve sleep and support your recovery journey.

Charleston, South Carolina
NCT06207162Recruiting
Brain scans and methadone treatment for opioid recovery

This study uses MRI scans over time to track brain changes in people with opioid use disorder who recently started methadone treatment. You can help researchers understand recovery patterns if you are early in your methadone journey and can commit to repeated visits.

New Haven, Connecticut
NCT06323824Recruiting· Phase 4
Methadone vs. buprenorphine for opioid use disorder treatment

This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.

Oakland, California
NCT06643988Recruiting
Memory and thinking study for opioid use disorder

This study looks at how people with opioid use disorder remember personal events. You'll do tasks on a cellphone and at home while taking medication for opioid use disorder.

Philadelphia, Pennsylvania

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.